Cosmos Health Files Patent Application for Multiple Sclerosis Treatment

MT Newswires Live
2025/02/06

Cosmos Health (COSM) filed a patent application for a treatment for multiple sclerosis.

This milestone highlights the partnership with Cloudpharm and the National Hellenic Research Foundation, supported by the pharma patent expert team at NLO Group, Cosmos Health said Wednesday in a statement.

The patent is based on data from Cosmos Health's artificial intelligence-powered Cloudscreen drug repurposing platform.

"Recent findings by Cosmos Health have demonstrated the potential of a repurposed marketed drug for treating MS, with the inventors identifying a unique mechanism of action," according to the statement.

MS is an autoimmune disorder that affects the central nervous system.

Price: 0.7096, Change: +0.0096, Percent Change: +1.37

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10